Reclassification of the drug could result in less restrictions on marijuana studies and lower tax rates for the cannabis industry. Read this story
Reclassification of the drug could result in less restrictions on marijuana studies and lower tax rates for the cannabis industry. Read this story
More from Forbes | stocks markets finance business cannabis marijuana weed Cannabis Drug Enforcement Administration